glp-1 market news november 2025 Size to Hit USD 212.73 Billion by 2035 GLP-1 Receptor Agonist Market Size

Recovery from relapse is associated with reduced inflammation, axon remyelination, and conduction restoration, decreasing the neurological symptoms and leading to remission

Healio coverage available at: Tsibadze N, Tskhakaia I, Tan I

Canadian Association for Suicide Prevention: Find a 24-hour crisis centre

This steady increase shows that more individuals are coming forward after experiencing serious side effects linked to GLP-1 drugs like Ozempic, Mounjaro, and Wegovy

Banik notes, While GLP-1 medications can improve glycemic control and reduce the progression of diabetic retinopathy, there is emerging evidence that they may be associated with a type of eye stroke

Sources Deane, A